Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-07-15 00:00:00 ET · period of report 2025-07-11 · accession 0001367644-25-000166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-15 | 2025-07-11 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $7.36 | -4,263 | 103.7K | -4% | -$31.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-11 | F | D | 4,263 | $7.36 | 103,692 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units. |